Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity.
about
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M).No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients
P2860
Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Efficacy of dual therapy with ...... nucleoside analogue toxicity.
@en
Efficacy of dual therapy with ...... nucleoside analogue toxicity.
@nl
type
label
Efficacy of dual therapy with ...... nucleoside analogue toxicity.
@en
Efficacy of dual therapy with ...... nucleoside analogue toxicity.
@nl
prefLabel
Efficacy of dual therapy with ...... nucleoside analogue toxicity.
@en
Efficacy of dual therapy with ...... nucleoside analogue toxicity.
@nl
P2093
P2860
P356
P1476
Efficacy of dual therapy with ...... nucleoside analogue toxicity.
@en
P2093
Ana Moreno
Carmen Santiuste
Miguel A Rodriguez
Santiago Moreno
Sara Bañón
P2860
P304
P356
10.1093/JAC/DKU402
P407
P577
2014-10-09T00:00:00Z